EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Current Features

Advertisement

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Current features

A CRO Should be the Partner that Gives Full Visibility on a Gene Therapy Trials Path

Ahead of ARVO 2025 next week where Emmes is poised to launch the first dedicated ophthalmology clinical trial technology platform, we spoke with Saqib Parkar, Managi...
Continue Reading →
Current features

Expert Predictions for 2025: Spotlight on Efficiency, AI, Regulatory, Risk and Better Communications

In 2024 the life sciences sector experienced high levels of cost pressure that drove process transformation in regulatory functions and smarter use of data and human...
Continue Reading →
Current features

Visualisation Approaches Coming to Light: Advances in Optical Imaging

Amidst the “burgeoning” interest in developing novel optical imaging drugs and imaging devices to assist various standard surgical procedures, the US Food and Drug A...
Continue Reading →
Current features

How Technology will Shape Pharma in 2025: Predictions from Veeva

As we advance through 2025, biopharma companies are increasingly using artificial intelligence (AI) and new data tools to improve commercial performance and make res...
Continue Reading →
Current features

Addressing Disparities in Clinical Research Participation in Genetically Based Rare Paediatric and Neurodevelopmental Diseases

We are at an important inflection point in our identification and understanding of genetically based diseases, particularly rarer paediatric-onset disorders that imp...
Continue Reading →
Current features

Imaging: Advancing Biomarker Research for Alzheimer’s Disease Diagnosis

Insights from the Bio-Hermes Trial A New Perspective on Alzheimer's Research Alzheimer's disease (AD) presents a significant challenge, not only for those diagnos...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

Company Profiles